• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病 MPTP 模型中小脑黑质和纹状体组织的蛋白质组分析。

Proteome analysis of substantia nigra and striatal tissue in the mouse MPTP model of Parkinson's disease.

机构信息

Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University, Beijing, P. R. China.

出版信息

Proteomics Clin Appl. 2007 Dec;1(12):1559-69. doi: 10.1002/prca.200700077. Epub 2007 Nov 16.

DOI:10.1002/prca.200700077
PMID:21136655
Abstract

The dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) replicates many of the pathological hallmarks of Parkinson's disease (PD) in mice via selective destruction of dopamine neurons of the substantia nigra and striatum. Although MPTP has been widely used to study downstream effects following the degeneration of dopaminergic neurons, the underlying mechanisms of MPTP action remain poorly understood. To determine the underlying mechanisms of MPTP action at the protein level, a 2-DE-based proteomics approach was used to evaluate the changes in protein expression in substantia nigra and striatal tissue in C57BL/6 mice after MPTP administration. We identified nine proteins that were markedly altered and are likely to be involved in mitochondrial function, heat shock protein activity, and which contribute enzyme activities for energy metabolism and protein degradation.

摘要

多巴胺能神经毒素 1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)通过选择性破坏黑质和纹状体中的多巴胺神经元,在小鼠中复制了帕金森病(PD)的许多病理特征。尽管 MPTP 已被广泛用于研究多巴胺能神经元退化后的下游效应,但 MPTP 作用的潜在机制仍知之甚少。为了确定 MPTP 在蛋白质水平上的作用机制,采用基于 2-DE 的蛋白质组学方法来评估 C57BL/6 小鼠给予 MPTP 后黑质和纹状体组织中蛋白质表达的变化。我们鉴定了 9 种明显改变的蛋白质,它们可能参与线粒体功能、热休克蛋白活性,并为能量代谢和蛋白质降解提供酶活性。

相似文献

1
Proteome analysis of substantia nigra and striatal tissue in the mouse MPTP model of Parkinson's disease.帕金森病 MPTP 模型中小脑黑质和纹状体组织的蛋白质组分析。
Proteomics Clin Appl. 2007 Dec;1(12):1559-69. doi: 10.1002/prca.200700077. Epub 2007 Nov 16.
2
Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.帕金森病1-甲基-4-苯基-1,2,3,6-四氢吡啶/丙磺舒渐进性神经退行性小鼠模型黑质致密部神经元凋亡的早期迹象。
Neuroscience. 2006 Jun 19;140(1):67-76. doi: 10.1016/j.neuroscience.2006.02.007. Epub 2006 Mar 14.
3
CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo.CEP-1347/KT-7515,一种c-jun氨基末端激酶激活抑制剂,可减轻1-甲基-4-苯基四氢吡啶在体内介导的黑质纹状体多巴胺能神经元损失。
J Pharmacol Exp Ther. 1999 Feb;288(2):421-7.
4
Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice.血管紧张素转换酶抑制剂培哚普利对MPTP处理小鼠中间神经元的影响。
Eur Neuropsychopharmacol. 2005 Jan;15(1):57-67. doi: 10.1016/j.euroneuro.2004.05.007.
5
SEA0400, a specific Na+/Ca2+ exchange inhibitor, prevents dopaminergic neurotoxicity in an MPTP mouse model of Parkinson's disease.SEA0400,一种特异性的钠/钙交换抑制剂,可预防 MPTP 诱导的帕金森病小鼠模型中的多巴胺能神经毒性。
Neuropharmacology. 2011 Dec;61(8):1441-51. doi: 10.1016/j.neuropharm.2011.08.041. Epub 2011 Sep 2.
6
Heat shock protein 70 kDa over-expression and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced nigrostriatal degeneration in mice.热休克蛋白 70kDa 过度表达和 1-甲基-4-苯基-1,2,3,6-四氢吡啶诱导的小鼠黑质纹状体变性。
Neuroscience. 2011 Oct 13;193:323-9. doi: 10.1016/j.neuroscience.2011.07.028. Epub 2011 Jul 20.
7
Role of nuclear transcription factor kappa B (NF-kappaB) for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine)-induced apoptosis in nigral neurons of mice.核转录因子κB(NF-κB)在1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)诱导的小鼠黑质神经元凋亡中的作用
Exp Mol Pathol. 2009 Feb;86(1):57-64. doi: 10.1016/j.yexmp.2008.10.004. Epub 2008 Nov 5.
8
Cyclooxygenases mRNA and protein expression in striata in the experimental mouse model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to mouse.1-甲基-4-苯基-1,2,3,6-四氢吡啶给药诱导的帕金森病实验小鼠模型纹状体中环氧合酶的mRNA和蛋白表达
Brain Res. 2004 Sep 3;1019(1-2):144-51. doi: 10.1016/j.brainres.2004.05.095.
9
Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.社交丰富化可减轻黑质纹状体损伤,并逆转进行性 1-甲基-2-苯基-1,2,3,6-四氢吡啶(MPTP)帕金森病小鼠模型的运动障碍。
Neurobiol Dis. 2012 Mar;45(3):1051-67. doi: 10.1016/j.nbd.2011.12.024. Epub 2011 Dec 14.
10
Neuroprotection in Parkinson models varies with toxin administration protocol.帕金森病模型中的神经保护作用因毒素给药方案而异。
Eur J Neurosci. 2006 Dec;24(11):3174-82. doi: 10.1111/j.1460-9568.2006.05192.x.

引用本文的文献

1
Systems biology analysis of the proteomic alterations induced by MPP(+), a Parkinson's disease-related mitochondrial toxin.帕金森病相关线粒体毒素MPP(+)诱导的蛋白质组学改变的系统生物学分析
Front Cell Neurosci. 2015 Feb 2;9:14. doi: 10.3389/fncel.2015.00014. eCollection 2015.
2
Proteomic profiling in MPTP monkey model for early Parkinson disease biomarker discovery.用于早期帕金森病生物标志物发现的MPTP猴模型中的蛋白质组学分析。
Biochim Biophys Acta. 2015 Jul;1854(7):779-87. doi: 10.1016/j.bbapap.2015.01.007. Epub 2015 Jan 22.
3
Anatomo-proteomic characterization of human basal ganglia: focus on striatum and globus pallidus.
人类基底神经节的解剖蛋白质组学特征:聚焦于纹状体和苍白球。
Mol Brain. 2014 Nov 18;7:83. doi: 10.1186/s13041-014-0083-9.
4
Neuroprotective effects of protocatechuic aldehyde against neurotoxin-induced cellular and animal models of Parkinson's disease.原儿茶醛对神经毒素诱导的帕金森病细胞和动物模型的神经保护作用。
PLoS One. 2013 Oct 18;8(10):e78220. doi: 10.1371/journal.pone.0078220. eCollection 2013.
5
Quantitative proteomic analysis of human substantia nigra in Alzheimer's disease, Huntington's disease and Multiple sclerosis.阿尔茨海默病、亨廷顿病和多发性硬化症患者黑质的定量蛋白质组学分析。
Neurochem Res. 2012 Dec;37(12):2805-13. doi: 10.1007/s11064-012-0874-2. Epub 2012 Aug 28.